Whilst chemotherapy drugs are expected to eradicate or slow the growth of cancer cellular material with no risk of everlasting side effects, recent lawsuits from women across the country allege that one of the most widely used chemotherapy drugs in the U. S. is usually creating long term hair reduction, or alopecia, in unsuspecting cancer patients. While frequently used on women suffering from breast cancer, almost all types of cancer sufferers are positioned at a higher risk of persistent alopecia if they have got been treated with pharmaceutic conglomerate Sanofi-Aventis’ drug, Taxotere. Taxotere is a superb chemotherapy medication that has prominently been used to treat advanced or metastasized breast malignancy. Estimates show that approximately 75% of women who have, or formerly got, breast cancer were treated with Taxotere under doctor’s suggestions without being warned of the substantially increased chance of suffering everlasting hair loss. Lawsuits allege that the drug’s manufacturers understood about the likelihood of long lasting alopecia in users as early as the 1990s, yet deliberately hidden it to downplay the risks associated with Taxotere.

Additionally, statements from a company whistle-blower allege that if you take benefit from vulnerable women’s insufficient knowledge about the medication and incentivizing doctors with “kickbacks” to prescribe the drug, Sanofi-Aventis was able to drastically increase Taxotere profits from $424 mil in 2000 to $1. 2 billion in 2005. Recent lawsuits also beg the question of why breast cancer patients had been not recommended similar medications on the market that did not have a risk of persistent alopecia, as the existence of alternative chemotherapy drugs that were at least as—if not more—effective than Taxotere has been long founded.

After a hard-fought fight with cancer, suffering everlasting hair loss from taking a drug you anticipated to heal you can feel like a series of compounding devastations. If you are today experiencing long lasting hairloss after taking Taxotere as a part of your breasts cancer treatment, our Taxotere legal representatives understand your frustration and anguish at becoming deceived with a multi-billion dollar pharmaceutical company. Permanent baldness in women can result in a lack of enjoyment of life, additional medical expenditures, psychological damage, and dropped wages for cancer survivors who only wish to return to a regular life. The legal group at Napoli Shkolnik PLLC is fully prepared to fight against deceptive pharmaceutical businesses on behalf of cancer of the breast survivors suffering everlasting Taxotere-related hair loss.